[Accutrend Plus(혈당,콜레스테롤,중성지방,젖산)]혈당, 콜레스테롤, 중성지방, 젖산을 한번에 빠르고 쉽게 검사하는 Accutrend Plus
혈당, 콜레스테롤, 중성지방, 젖산검사!
Glucose! Cholesterol! Triglycerides! Lactate!
빠르고 간편하게 사용하는 Accutrend Plus!
Quick! Who needs to be screened for cardiovascular disease?
Accutrend Plus: Spot on. On the spot.
Simple monitoring, rapid results Total cholesterol, triglycerides and blood glucose
levels can be used to identify those patients at risk of CVD.
Regular monitoring of these parameters provides important information about disease progression.
Accutrend Plus lets you measure the key parameters of cardiovascular disease on the spot.
Safely, reliably and easily.
Quick and convenient, Accutrend Plus puts the measurement of CVD risk factors in the palm of your hand.
□ Specification
- Flexible, hand-held point of care device for the three key parameters – total cholesterol, triglycerides and glucose.
- Cost effective, all-in-one device that provides excellent assay performance when compared with standard laboratory tests.
- Store up to 100 different measurements with date, time and
high-low flags.
□ Three simple steps, accurate results
- Step One:
Switch the instrument on and insert a test strip. A flashing arrow tells you to open the device to apply the blood sample.
- Step Two:
Use the lancing device, collect capillary blood and apply this directly onto the strip (alternatively, you can apply blood onto the test strip outside the device and then reinsert the strip).
- Step Three:
Close the device and wait for your results. When the measurement is complete, values are displayed and high or low values indicated.
□ Test
□ References
1 Klingman, D., et al. (2005), Gauging the treatment gap in dyslipidemia: findings from the 1999–2000 National Health and Nutrition Examination Survey. Am Heart J 150: 595–601
2 WHO, MacKay, J. and Mensah, G.A. (2004), The Atlas of Heart Disease and Stroke
3 Cardium Study #4, Dyslipidemia Decision Resources, Inc. Waltham, MA (2007)
4 Yach, D., et al. (2004), The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 291: 2616–2622
5 Clearfield, M.B. (2003), Underidentification and undertreatment of dyslipidemia.
J Am Osteopath Assoc 103: 5-8
6 Petersen, S., et al. (2005) European cardiovascular disease statistics. 2nd Edition.
European Heart Network and the British Heart Foundation
□ Cotact & Ask
Medical Device Korea
TEL : 02 553 0923
